**Question:** Which of the following statements is true regarding theophylline?

A. Theophylline is a selective adenosine A2A receptor agonist.
B. Theophylline is a selective phosphodiesterase inhibitor.
C. Theophylline is a selective adenosine A1 receptor antagonist.
D. Theophylline is a selective adenosine A3 receptor agonist.

**Core Concept:** Theophylline is a phosphodiesterase inhibitor and adenosine receptor modulator used to treat respiratory distress in patients with asthma and chronic obstructive pulmonary disease (COPD).

**Why the Correct Answer is Right:**

A. The correct answer is B, "Theophylline is a selective phosphodiesterase inhibitor."

Phosphodiesterases (PDEs) are enzymes that break down cyclic AMP (cAMP) and cyclic GMP (cGMP) into their respective mononucleotides. Inhibition of PDEs leads to increased levels of cAMP and cGMP, which can have bronchodilatory effects on the smooth muscles of airways. Theophylline is a nonselective PDE inhibitor, meaning it inhibits multiple PDE isoforms. By inhibiting these enzymes, theophylline increases intracellular cAMP levels, leading to bronchodilation and reduction of airway inflammation.

**Why Each Wrong Option is Incorrect:**

A. Theophylline is not a selective adenosine A2A receptor agonist (option A). Selective adenosine A2A receptor agonists, like CGS 21680, have been developed as potential treatments for diseases like Parkinson's disease and schizophrenia. Theophylline's mechanism of action is different from that of selective A2A agonists.

B. Theophylline is not a selective adenosine A1 receptor antagonist (option C). Selective adenosine A1 receptor antagonists, like DPCPX, have been used to study the role of adenosine in various physiological processes. Theophylline's mechanism of action is different from that of selective A1 antagonists.

D. Theophylline is not a selective adenosine A3 receptor agonist (option D). Selective adenosine A3 receptor agonists, like Clopentoxyl, have been studied for their anti-inflammatory effects. Theophylline's mechanism of action is different from that of selective A3 agonists.

C. Theophylline is not a selective phosphodiesterase inhibitor (option B). Selective PDE inhibitors like milrinone and amrinone have been developed for their positive inotropic effects in heart failure patients. Theophylline's mechanism of action is different from that of selective PDE inhibitors.

**Clinical Pearl:** Theophylline's bronchodilatory effects are primarily due to its inhibition of phosphodiesterase enzymes, which leads to increased cAMP levels and bronchodilation in airways.

**Why Theophylline is used:**

Theophylline is primarily used for its bronchodilatory properties. The drug inhibits phosphodiesterase enzymes, thereby increasing intracellular cAMP levels, which leads to relaxation of airway